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ABSTRACT
Objectives: The main objective was to study the prescribing practice of antibiotic in hospital in-patient is to assess the prescribing patterns 
of antibiotics in children who were admitted in a tertiary care hospital regarding respiratory tract infections and to check out which category of 
antibiotics are most prescribed.
Methods: The study which includes a retrospective monitoring of pediatrics undergoing treatment with diff types of antibiotics were carried out for 
a period of 6 months both in-patient as well as outpatient.
Results and Discussion: A total of 50 patients were screened. The most common category of antibiotic prescribed is aminoglycosides (48%), 
broad-spectrum antibiotics (29%), cephalosporins (14%), and fluoroquinolones (7%) macrolides (2%). 48% were admitted with common cough 
and cold accompanied by fever, 24% with bronchopneumonia, 14% with bronchial asthma, 12% with bronchitis, 2% with pneumonia. The number 
of antibiotics per prescription ampicillin with garamycin were 51%, cefuroxime with garamycin were 21%, ciprofloxacin with garamycin were 
10%, cefotaxime with garamycin was 7%, ciprofloxacin with amoxicillin was 2%, single antibiotic prescribed are cefuroxime (2%), garamycin 
(4%), ciprofloxacin (4%). Adverse drug events were detected in sample size n=50 were 6% for drugs with ampicillin (rashes *4 days), ciprofloxacin 
(loose stools *2 days).
Conclusion: In order to reduce the risk of antibiotic resistance of microbes, an antibiotic policy should be carefully instituted and implemented. The 
doses prescribed to the pediatrics should be calculated according to the weights in order to avoid adverse drug reactions.
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INTRODUCTION
Pediatrics is the branch of medicines dealing with the development, 
diseases, and disorders of children [1]. Infancy and childhood is a period 
of rapid growth and development. Compared to adult medicine, drug 
use in pediatrics is not extensively researched and the range of licensed 
drugs inappropriate dosage form is limited. Drug therapy is considered 
to be a major component of pediatric management in healthcare setting 
like hospital. The use of antimicrobial agents, especially antibiotics has 
become a routine practice for the treatment of pediatric illnesses [2,3]. 
The key role of antibiotics for the treatment of infectious diseases that 
are prevalent everywhere in developing countries may not be denied. 
However, there are also reports of an irrational use of antibiotics [4,5] 
which may even lead to infections that are worse than the originally 
diagnosed ones.
Antibiotics may be informally defined as the subgroup of anti-infectives 
that are derived from bacterial sources and are used to treat bacterial 
infections. Other classes of drugs, most notably the sulfonamides, 
may be effective antibacterials. Similarly, some antibiotics may have 
secondary uses, such as the use of demeclocycline (declomycin, 
a tetracycline derivative) to treat the syndrome of inappropriate 
antidiuretic hormone secretion. Other antibiotics may be useful in 
treating protozoal infections.
Various drug prescription problems have been identified in health 
facilities in developing countries. This includes the irrational 
use of drugs, unnecessary polypharmacy and high use of drugs 
with unproven efficacy. Some of these studies have shown that 
antibiotics are one of the most commonly prescribed drugs among 
physicians and have identified its overuse [6] Antibiotic resistance 
can be tackled by effective auditing of production of the drugs 
manufacturers, sales by wholesalers and retailers, and prescription 
by health care professionals. Standard of treatment of ailments have 
been found to be improved at all levels of the health care system 
if a medical audit is done. The National Drug Policy has also made 
recommendations for ensuring proper drug use [7]. Essential drug 
lists and standard treatment guidelines also serves as a guide in 
diagnosing, management, and treatment of medical conditions 
among health workers in order to promote the rational use of drugs 
by prescribers, dispensers and consumers as stated in the National 
drug policy.
Asthma
Asthma can be defined as a chronic inflammatory disorder of the airways, 
characterized by recurrent episodes of wheezing, breathlessness, chest 
tightness, and cough that is often reversible, either spontaneously or 
with treatment. Different terms such as allergic or asthmatic bronchitis, 
wheezy bronchitis, intrinsic, and extrinsic asthma are frequently 
employed in clinical practice.
Pneumonia
Pneumonia is a lung infection involving the lung alveoli (air sacs) and 
can be caused by microbes, including bacteria, viruses, or fungi.
Pneumonia  an infection of the small air sacs of the lungs (alveoli) and 
the tissues around them and is one of the most common causes of death 
worldwide. Often, pneumonia is the final illness in people who have 
other serious, chronic diseases [8].
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Bronchitis
Bronchitis is swelling and irritation in the air passages, that is, the tubes 
that connect the windpipe to the lungs. It causes swelling and irritation 
of the airways. With acute bronchitis, you usually have a cough that 
produces phlegm and pain behind the breastbone when you breathe 














Total sample size was 50 prescribed antibiotics per patient were noted. 
Similarly, admission and discharge diagnosis, and the condition of the 
patients on admission and discharge were recorded. Moreover, drug data, 
including name of the drug, dosage regimen (form, route, frequency and 
duration), and the date on which the pharmacotherapy was instituted, 
were recorded. Blood transfusion and nutritional preparations were 
not included in the study. The prescribing indicators according to WHO 
measure the performance of health care providers [7]. The indicators 
are based on the practices observed in a sample of clinical encounters 
taking place at outpatient health facilities for the treatment of acute or 
chronic illness. These encounters can be observed retrospectively, from 
data recorded in historical medical records, or they can be observed 
prospectively, from a group of patients attending the clinic on the day 
the data are collected.
RESULTS
Drug data and patient characteristic data were computed using Ms 
Excel (Tables 1 and 2).
The total number of study population was 50 of which 62% were male 
and 38% were female.
Among the study population, the age was ranging from 0 to 12 years. 
The age was differentiated into 3 groups such as infants from 1 month 
to 1 year, followed by young kids ranging from 1 to 6 years, followed 
by old kids from 7 to 12 years. The numbers of young kids were 
58% age 1-6 years, followed by old kids 26% age between 7 and 12, and 
16% were below 1 year named infants. This data shows that the age 
group between 1 and 6 years were more affected by respiratory tract 
infections (Table 3).
Frequency percentage of antibiotics prescribed for specific diagnosis 
was assessed. It shows that garamycin (aminoglycosides) is the most 
prescribed antibiotic (45), except for pneumonia. Second, comes the 
ampicillin (broad spectrum antibiotic) (26). Followed by, cefuroxime 
(cephalosporin) (13), except for bronchial asthma, and pneumonia. 
Ciprofloxacin (7) later ceftriaxone and erythromycin last but not the 
least usage of drug is amoxicillin (Table 4).
Among dosage forms, 47% were oral, 23% were parenteral, 13% 
cough syrups, 8% vitamins, 5% nebulizers, and 4% bronchodilators 
(Tables 5-10).
DISCUSSION
The number of male patients was comparatively more than the number 
of female patients. Of them, 16% were infants, 58% were young 
kids (1-6 years), 26% were old kids (7-12 years). Of the entire study 
sample, total number of antibiotics are 96 (26%) were encountered 
in a survey and (96%) of them were given two or more antibiotics 
remaining (10%) were single therapy antibiotics. The most common 
category of antibiotic prescribed is aminoglycosides (48%), broad-
spectrum antibiotics (29%), cephalosporins (14%), fluoroquinolones 
(7%), and macrolides (2%). Diagnosis patterns in different age group 
was analyzed it was found  that 48% were admitted with common 
cough and cold accompanied by fever, 24% with bronchopneumonia, 
14% with bronchial asthma, 12% with bronchitis, 2% with pneumonia. 
According to WHO prescribing indicators, average drugs per 
prescription were found to be 7.2% of encounters of antibiotics and 
injections prescribed (25.2%), percentage of drugs prescribed from 
essential drug list (94.8%). Total Antibiotics prescribed for males 54% 
for females 38%. The number of antibiotics per prescription Ampicillin 
with garamycin was 51%, cefuroxime with garamycin were 21%, 
ciprofloxacin with garamycin were 10%, cefotaxime with garamycin was 
7%, ciprofloxacin with amoxicillin was 2%, single antibiotic prescribed 
are cefuroxime (2%), garamycin (4%), ciprofloxacin (4%). Adverse 
drug events were detected in sample size n=50 were 6% for drugs with 
ampicillin (rashes *4 days), ciprofloxacin (loose stools *2 days).
CONCLUSION
In order to reduce the risk of antibiotic resistance of microbes, an 
antibiotic policy should be carefully instituted and implemented. The 




Table 2: Age distribution of diseases










Fever with cough 
and cold (%)
Infants<1 year 16 0 0 2 6 8
Young kid 1-6 years 58 6 2 10 10 30
Old kid 7-12 years 26 8 0 0 8 10
Table 3: Frequency of individual antibiotic for specific diagnosis
Diagnosis Ampi Gara Amox Cipro Cefita Cefuro Erythro
Bronchial asthma 6 6 1 2 0 0 0
Pneumonia 0 0 0 0 0 0 0
Bronchitis 4 6 0 1 0 2 0
Bronchopneumonia 9 12 0 2 0 2 0
Fever with cough and cold 7 21 0 2 2 9 2
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doses prescribed to the pediatrics should be calculated according to the 
weights in order to avoid adverse drug reactions.
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Bronchial asthma 0 6 8 14
Pneumonia 0 2 0 2
Bronchitis 2 10 0 12
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cough
8 30 10 48





Cough syrup 38 (13)
Bronchodilators 12 (4)
Nebulizers 15 (5)
Table 6: Children health-related history according to their 
parents
Antibiotic usage/year Never Once 2-3 times 4-5 times
Bronchial asthma 0 3 4 4
Bronchitis 0 1 5 0
Pneumonia 0 1 0 0
Bronchopneumonia 0 3 9 4
Fever with cough and cold 4 5 15 5
Table 7: Number of antibiotics/prescription









Table 8: Antibiotics prescribed for male and female






Table 9: Appropriateness of antibiotics prescribed in Tertiary 
Care Hospital
Name Dose Strength Frequency
Over Under Optimum Correct Correct Incorrect
Ampicillin 0 5 21 21 21 0
Gentamycin 5 8 30 30 30 0
Ciprofloxacin 0 1 6 6 6 0
Cefuroxime 0 0 6 6 6 0
Amoxicillin 0 0 1 1 1 0
Cefotaxime 0 0 2 2 2 0
Erythromycin 0 0 2 2 2 0
Table 10: Reasons for admission
Reasons for admission Patient (%)
Fever 82 (41)
High grade 42 (21)





Abdominal pain 24 (12)
Throat pain 10 (8)
Dyspnoea 4 (2)
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